Literature DB >> 2958930

Separate but complementary roles for the two forms of interleukin 1 in the growth of transformed human B lymphoblasts.

G Gallagher1, N Taylor, J Willdridge.   

Abstract

Epstein-Barr virus (EBV)-transformed human B cells were seeded at densities below their capacity for autostimulatory growth and the effects of interleukin 1-alpha (IL-1-alpha), interleukin 1-beta (IL-1-beta) and B-cell growth factor (BCGF) were studied. When added separately, IL-1-alpha was able to support the growth of EBV-transformed B cells, as was BCGF. In contrast, IL-1-beta was unable to support the growth of these cells but was able to synergize with IL-1-alpha to promote cell growth. Further, the actions of BCGF and IL-1-alpha were seen to be synergistic, while those of BCGF and IL-1-beta were not. The secretion of immunoglobulin was not affected by these reagents. These findings suggest separate, but complementary roles for the two forms of human IL-1 in B-cell growth.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2958930     DOI: 10.1111/j.1365-3083.1987.tb02263.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Interleukin-6 enhances the induction of human lymphokine-activated killer cells.

Authors:  G Gallagher; W H Stimson; J Findlay; F al-Azzawi
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  A study of the pyrogenic actions of interleukin-1 alpha and interleukin-1 beta: interactions with a steroidal and a non-steroidal anti-inflammatory agent.

Authors:  J Davidson; A S Milton; D Rotondo
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

3.  Interleukin-3 and interleukin-4 each strongly inhibit the induction and function of human LAK cells.

Authors:  G Gallagher; F Wilcox; F al-Azzawi
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.